Table 2.
Host Genes Involved in MNoV Regulation. Mouse genes implicated in viral infection, innate immune control, and adaptive immune control of murine norovirus are presented. MNV-1 and MNV-1.CW3 (here CW3) are acute strains of MNoV that infect systemic organs and are cleared by wild-type (WT) mice, while CR3, CR6, MNV/Hannover, and MNV-3 are persistent strains of MNoV that infect the intestine, are shed into the feces, and are not cleared in WT mice.
| Viral infection | |||||
|---|---|---|---|---|---|
| Gene | Role | MNoV strain(s) | In vitro effect | In vivo effect | Refs |
| Cd300lf and CD300ld | Viral receptors | CW3/CR6 | Myeloid cell lines and primary macrophages lacking Cd300lf or CD300ld are not infected | Oral CR6 infection is prevented in Cd300lf−/− mice | [44,45] |
| Rag2 and Il2rg | Development of Peyer’s patches and M cells | CW3/CR3 | MNoV is transcytosed by M-cell-like murine intestinal epithelial mlCcl2 cells | Oral MNoV infection is reduced in mice lacking M cells | [37,38] |
| Innate immunity | |||||
| Gene | Role | MNoV strain(s) | In vitro effect | In vivo effect | Refs |
| Mda5 | Viral recognition | MNV-1 | Higher viral replication and defective cytokine response in Mda5−/− dendritic cells | Higher viral replication in Mda5−/− mice | [64] |
| Tlr3 | Viral recognition | MNV-1 | No effect observed | Higher viral replication in Tlr3−/− mice | [64] |
| Nlrp6 | Viral recognition | MNV-1 | N/A | Higher viral replication and levels of fecal shedding in Nlrp6−/− mice, and virus persists in Nlrp6−/− mice | [65] |
| Irf3 | Induction of IFN | CW3 | Irf3−/−Irf7−/− dendritic cells and macrophages show higher viral replication, and macrophages show impaired IFN production | Higher viral replication in Irf3−/− mice | [60] |
| CR6 | N/A | Irf3−/− mice are resistant to the effects of antibiotics in preventing infection | [68] | ||
| Irf7 | Induction of IFN | CW3 | Irf3−/−Irf7−/− dendritic cells and macrophages show higher viral replication, and macrophages show impaired IFN production | Higher viral replication in Irf7−/− mice | [60] |
| Ifnar1 | Type I IFN response | MNV-1/CW3 | Ifnar1−/− dendritic cells and macrophages show higher viral replication | Ifnar1−/− mice succumb to lethal infection, virus replicates to higher level, and virus persists in conditional knockout mice lacking Ifnar1 in dendritic cells or macrophages | [8,9,60–63] |
| CR6 | N/A | Enteric virus infects systemically in Ifnar1−/− mice | [68,69] | ||
| Ifngr1 | Type II IFN response | CW3 | N/A | Addition of Ifngr1 deficiency to type I IFN receptor deficiency causes increased viral replication and mortality | [61,66] |
| Ifnlr1 | Type III IFN response | CR6 | N/A | Higher viral replication and levels of fecal shedding in Ifnlr1−/− mice, and Ifnlr1−/− mice are resistant to the effects of antibiotics in preventing infection | [67,68] |
| Stat1 | Type I, II, and III IFN response | MNV-1/CW3 | Stat1−/− dendritic cells and macrophages show higher viral replication, and Stat1 is required for IFN-γ-mediated inhibition of MNoV replication in macrophages | Stat1−/− mice succumb to lethal infection | [8,9,66] |
| CR6 | N/A | Higher viral replication and levels of fecal shedding in Stat1−/− mice, and Stat1−/− mice are resistant to the effects of antibiotics in preventing infection | [67,68] | ||
| Irf1 | Type II IFN Response | CW3 | Irf1 is required for IFN-γ-mediated inhibition of MNoV replication in macrophages | Addition of Irf1 deficiency to type I IFN receptor deficiency causes increased viral replication and mortality | [66] |
| Atg5-Atg12, Atg7, and Atg16L1 | Type II IFN response | CW3 | Atg5–Atg12, Atg7, and Atg16L1 are required for IFN-γ-mediated inhibition of MNoV replication in macrophages | Addition of macrophage-specific Atg5-deficiency to type I IFN receptor deficiency causes increased viral replication and mortality | [61] |
| CR6 | N/A | Persistent viral infection induces intestinal pathology in Atg16L1-hypomorphic mice, dependent upon TNF-α and IFN-γ, though viral levels are similar to wild-type mice | [71] | ||
| Il10 | Anti-inflammatory cytokine | MNV/Hannover1 | N/A | Persistent viral infection induces intestinal pathology in Il10-deficient mice; though overall viral levels are similar to wild-type mice, MNoV localization is altered at early time points in knockout mice | [72] |
| Adaptive immunity | |||||
| Gene | Role | MNoV strain(s) | In vitro effect | In vivo effect | Refs |
| Rag1 | B- and T-lymphocyte development | CW3/MNV-3 | N/A | MNoV persists in Rag1−/− mice, and adoptively transferred immune splenocytes can clear infection; adoptively transferred MNV-specific CD8+ T cells can decrease viral loads | [63,73–75] |
| Ighm/muMt | B-lymphocyte development | CW3/MNV-3 | N/A | MNoV persists in muMt−/− mice; adoptively transferred immune splenocytes derived from B-cell-deficient mice or antibody production-deficient mice are unable to efficiently clear persistent infection in Rag1−/− mice; B cells are critical for protective immunity | [63,73,74,76] |
| MHC II | CD4+ T-cell development | CW3/MNV-3 | N/A | MHC II −/− mice have higher viral titers in the ileum than wild-type mice, but clear infection normally; CD4+ T cells are critical for protective immunity | [63,74,76] |
| MHC I and β2M | CD8+ T-cell development | CW3 | N/A | MNoV persists in MHC I × β2M−/− mice for longer periods than in wild-type mice, but is eventually cleared; acute control of virus is also regulated by CD8+ T cells | [74,76] |